Join to view full profile
1710 N. Randall Rd.Ste. 300Elgin, IL 60123
Phone+1 847-931-0909
Fax+1 847-488-9596
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Apurva Desai, MD is an oncologist in Elgin, Illinois. He is currently licensed to practice medicine in Illinois. He is affiliated with Advocate Lutheran General Hospital.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1999 - 2002
Rush University Medical CenterResidency, Internal Medicine, 1995 - 1999
University of Illinois College of MedicineClass of 1995
Certifications & Licensure
IL State Medical License 1997 - 2029
IL State Medical License 1995 - 2026
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification OncoEMR by Flatiron Health, Flatiron Health, Inc., 2013-2014, 2016-2017
Publications & Presentations
PubMed
- 15 citationsA phase I dose-escalation study of the polyamine analog PG-11047 in patients with advanced solid tumorsTracy Murray Stewart, Apurva A. Desai, Michael L. Fitzgerald, Laurence J. Marton, Robert A. Casero
Cancer Chemotherapy and Pharmacology. 2020-05-23 - 20 citationsVascular endothelial growth factor pathwayMichael L. Maitland, Xing Jian Lou, Jacqueline Ramírez, Apurva A. Desai, Dorit S. Berlin
Pharmacogenetics and Genomics. 2010-05-01 - 861 citationsSorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation TrialBernard Escudier, Tim Eisen, Walter M. Stadler, Cezary Szczylik, Stéphane Oudard
Journal of Clinical Oncology. 2009-07-10










